Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3048

Actual shortage: 226 (7%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2799 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-12 2024-03-22 215973
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-19 2024-02-09 216662
APO-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-03-22 216687
APO-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-03-05 216690
APO-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-04-23 216693
APO-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-04-19 216696
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-26 2024-02-23 217300
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-26 2024-05-24 217481
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2024-02-02 2024-02-23 218376
APO-DICLO SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2024-02-09 2024-04-19 219177
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 100MG TABLET (EXTENDED-RELEASE) Resolved 2024-02-23 2024-03-29 220465
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-01 2024-03-22 221096
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-08 2024-03-15 221717
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-05-24 225770
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-05-24 225779
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-26 225793
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Resolved 2023-03-09 2023-04-14 186586
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216699
APO-QUETIAPINE FUMARATE 100MG TABLET (IMMEDIATE RELEASE) Anticipated shortage 2024-01-19 2024-02-06 216702
APO-QUETIAPINE FUMARATE 200MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-05-08 216705

Showing 2981 to 3000 of 3048

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-CETIRIZINE Discontinued 2018-05-31 2018-05-31 50998
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-09-07 2018-09-15 60241
APO-CYCLOSPORINE ORAL SOLUTION Discontinued 2018-09-07 2018-09-15 60408
APO-FAMOTIDINE TAB 20MG USP Discontinued 2018-09-07 2018-09-15 60477
APO-FAMOTIDINE TAB 40MG USP Discontinued 2018-09-07 2018-09-15 60480
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-LATANOPROST-TIMOP Discontinued 2018-09-07 2018-09-15 60572
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RIZATRIPTAN RPD Discontinued 2018-09-08 2019-04-02 60756
APO-SILDENAFIL R Discontinued 2018-09-08 2018-09-15 60787
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-12-21 2018-12-24 70347
APO-TIMOP Discontinued 2019-01-02 2019-01-02 70818
ACID CONTROL Discontinued 2019-01-03 2019-01-03 70906
APO-OFLOXACIN Discontinued 2019-01-03 2019-01-03 71017
APO-TIMOP GEL Discontinued 2019-01-03 2019-01-03 71020
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71029

Showing 1 to 20 of 356